LONDON - GSK plc, the global healthcare company, has released its Annual Report for the fiscal year ending December 31, 2024. The report was published on the company's website today and is also set to ...

However, the company faces intense competition in this space, with established players like Pfizer and GlaxoSmithKline holding strong market positions. Moderna’s ability to capture market share with ...

The stock of GlaxoSmithKline Pharmaceuticals (GSK Pharma) hit a three-month high of ₹2,640 a share as it surged 5 per cent on Monday before closing at ₹2,638. During the past seven trading days, the ...

However, the company faces intense competition in this space, with established players like Pfizer and GlaxoSmithKline holding strong market positions. Moderna's ability to capture market share ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other pharmaceutical stocks. Almost no other industry goes as far as the phrase "defensive" as the ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. UK drugmaker GSK is struggling to convince the market that it can deliver on its plans to refill its ...

The PMCPA has turned party pooper, coming down on GSK after learning that a U.K. employee celebrated a post about a prescription drug on LinkedIn. A panel of leaders at the PMCPA, pharma’s ...

GSK Plc is a long-term underperformer among Europe’s Big Pharma stocks. And with key drug patents set to expire and vaccine sales falling, some market participants say it may draw in activist ...